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Abstract
Infant and maternal mortality are important indicators for assessing the quality of healthcare
systems. The World Health Organization underscores the importance of proper health care
system in reducing preventable mortality through early intervention. Early intervention
includes availability, accessibility and affordability of health care systems for children and
mothers. While there are several studies that assess the immediate and underlying drivers
of child mortality, literature on the role of policy measures are limited and inconsistent. Thus,
robust empirical analysis of the determinants of maternal and infant mortality remains incon-
clusive in the era of achieving the Sustainable Development Goals (SDG). Here, we exam-
ined the influence of health expenditure on infant and maternal deaths for the period 2000–
2015 across 177 countries. Using panel Quantile Regression with bootstrapping, this study
accounted for the 2007–2008 financial crisis in an empirical relationship between health out-
come and health expenditure. We found a negative effect of health expenditure on mortality
across all percentiles. Infant mortality rate declines between 0.19% - 1.45% while maternal
mortality rate declines ranging from 0.09% - 1.91%. To attain the goal of ensuring healthy
lives and wellbeing of all people (SDG 3), this study infers that health expenditure potentially
reduces maternal and infant mortality across lower and middle income countries. We high-
light the need for an enhanced health care expenditure, especially in developing countries to
curb the levels of infant and maternal deaths.
Introduction
The impact of the health care system on human life (health outcome) has over the years trig-
gered public health concern among policymakers to find a lasting solution (sustainable
options). Thus, in the year 2015, the sustainable development goals (SDGs) were developed.
The goal 3 of the SDGs, seeks to promote ‘good health and wellbeing for all and at every stage
(from conception to old age) in one’s lifetime’ [1]. As part of achieving SDG 3 and universal
health coverage, there is a need for good health care systems to be in place. The health care sys-
tem is made up of various sectors or branches of which cost or financing cannot be left out as
it is one of the objectives of SDG 3 (strengthening health financing).
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In assessing the health status of any given country, maternal and infant mortality rate indi-
cators of avoidable or treatable conditions play a vital role in assessing population health, qual-
ity of care, poverty, and socioeconomic status, among others. Approximately 303 thousand
women died globally in 2015 owing to pregnancy and childbirth causes with the majority of
deaths recorded in low- and middle-income nations. In 2016, 2.6 million deaths of new-borns
were recorded [2].
Health status in general, as well as, the mortality rate at various stages of life in developed,
developing, and least developed countries vary based on several factors. The government/
health insurance/private funds (out-of-pocket, NGOs, private corporations) spending in health
(health expenditures) are few of the factors that mortality rate varies greatly from country to
country [3]. The mortality rates and health spending to some extent differ from state to state
within countries.
Considering this, the study seeks to examine the overarching effect of health care expendi-
ture on mortality (maternal and infant). Maternal and infant mortality are considered because,
majorly, they are vulnerable in the society, and governments spending on health are mostly
not categorized based on the type of care (primary, secondary, and tertiary) provided.
The relationship between health outcome (mortality) and health expenditure has been stud-
ied over the years either for an individual (time series) or a group of countries (such as OECD,
sub-Saharan Africa). However, these studies have varying results with different data sets and
methods used especially for maternal mortality ratio [4–10]. As pointed out in a recent study
[9], an investigation of this kind requires accounting for “unobserved heterogeneity”, a chal-
lenge that most existing literature fails to address. As a contribution to health economics litera-
ture, this study employs a quantile estimation method with a bootstrapping technique that
controls for heterogeneous parameters across countries and quantiles (0.05,. . ., 0.95). The
advantage of this model estimation is that the conditional distribution of the nexus between
mortality and expenditure can be estimated in detail across different quantiles (0.05,. . ., 0.95)
─ a situation that differs in extant literature. This characteristic of the panel data method is
useful in global studies that consider diverse income groups and requires policy formulation
for different scenarios ─ a conceptual tool that is required in this study.
Our study demonstrated that improving healthcare expenditure has greater impact in
reducing infant and maternal mortality in developing countries compared to high-income
countries. This implies that policies that make healthcare availability, accessibility and afford-
ability in low-income countries, have mitigating effects on infant and maternal mortality.
Thus, private and governmental bodies can invest and ensure appropriate allocation of health
system-based monetary resources to achieve desirable health outcomes (reduced morbidity
and mortality).
Theoretical background of the study
Infant and maternal health outcomes are measures that gained a lot of attention in the early
90s in both developed and developing economies. To improve the health outcomes of mothers
and children under age 5, the Millennium Development Goals (MDGs) 4 and 5 were set by
United Nations (UN) member states in 2000 to achieve a reduction in child deaths and
improve maternal health by 2015 [11]. At the end of the period, MDGs 4 and 5 were achieved
to an extent in developed nations but was limited in developing and least-developed nations
among the UN member states. Thus, the global infant mortality rate from 1990 (64.7 deaths
per 1,000 live births) dropped considerably over the years by 54.6% (29.4 deaths per 1,000 live
births in 2017) but its impact still lingers in developing countries. The annual maximum and
minimum IMR for the study period is 142 and 1.7 deaths per 1,000 live births, respectively.
PLOS ONE Mortality and health care expenditure nexus
PLOS ONE | https://doi.org/10.1371/journal.pone.0247413 February 24, 2021 2 / 15
MMR from 1990 (385 deaths per 100,000 live births) to 2015 (216 deaths per 100,000 live
births) have been decreasing but at a slower pace compared to IMR in terms of the global aver-
age. MMR from 2000–2015 recorded as high as 2,650 deaths and as low as 3 deaths per
100,000 live births.
To resolve this in developing and underdeveloped nations, there is a school of thought that
increasing health spending can reduce infant and maternal deaths while impacting universal
health coverage. But, other contributing factors aside health spending play a critical role ─ of
which, there exist several studies with varying results [4].
To better understand the situation at hand, a review of existing published literature on the
topic is explored. The results of the nexus between health spending and mortality (under-5
and infant) using Ordinary Least Squares regression among other methods found health
spending as an insignificant determinate of mortality [5]. A similar study examined how state
health expenditure affects infant mortality among states in India for the period 1961 to 1999
using probit static model and distributed lag model [6]. The results show that government
spending did appear not to save lives in India, but found otherwise for rural households sam-
ple by allowing lagged effects. In research on health expenditure and health outcomes for the
period 1995–2005 for OECD countries, the findings showed a significant impact of health
spending reducing infant mortality, increasing life expectancy, and increasing potential life
years lost, but not valid for maternal mortality [7]. A study for seven (7) countries in the sub-
Saharan region of Africa revealed that there exists a nexus between gender inequality, health
expenditure, and maternal mortality for the study period [8]. The relationship between health
expenditure and mortality (infant, under-5, and maternal) for the period 1995–2014 showed a
significant relationship between health expenditure and child mortality [9]. However, an insig-
nificant relationship was found between health expenditure and maternal mortality. In
Mexico, a study for the period 2000–2015 was investigated between government health expen-
diture maternal health, and maternal mortality (focus on Mexican poor population). The find-
ings showed the ineffectiveness of government health expenditure in reducing maternal
mortality [10].
Disruptions in financial markets hamper economic development, thus, affecting livelihood
and welfare (declines household income and expenditure). A study showed that the economic
crisis of Peru (started in 1988) impacted infant mortality by recording more deaths than
expected in the absence of the crisis [12]. Therefore, the global financial crisis (FC) affects
health expenditure—as a share of economic growth, thus, justifies the controlling of the global
FC period 2007–2008 in this study for the study period (2000–2015).
Materials and methods
Data
The data series examined in this analysis are annual data series of Infant Mortality rate (IMR,
per 1,000 live births), Maternal mortality ratio (MMR, modelled estimate, per 100,000 live
births), and Current health expenditure (CHE, % of GDP). We selected 177 countries
(n = 177, see S1 Appendix in S1 File) from the seven continents (South America, North Amer-
ica, Europe, Antarctica, Africa, Asia, and Australia) of the world due to data limitation (avail-
ability and missing data). The period for the analysis spans from 2000 to 2015 (T = 16
periods). Data were obtained from the World development indicators [13]. S2 Appendix in S1
File illustrates the descriptive statistics of data variables for its raw and logarithmic trans-
formed state. Current health expenditure is defined as the total spending on health care
‘goods’ and ‘services’ “including personal health care [curative care, rehabilitative care, long-
term care, ancillary services, and medical goods] and collective services [prevention and public
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services as well as health administration]” [3]. This CHE spending does not factor in costs from
investments (machinery, stocks of vaccines for emergency or outbreaks, information technolo-
gies, and buildings). The world CHE in 2016 was 10.02% of GDP. A [14] statistical examina-
tion of the data shows that the mean CHE is 6.09% of GDP while the maximum and minimum
are 20.41% and 1.03% of GDP, respectively [13]. This provides evidence of varying health
expenditure across countries. The selection and inclusion of health expenditure, as a proxy
variable for enhanced health care delivery stem from the Sustainable Development Goal
(SDG) 3 of ensuring and promoting a healthy lifestyle and wellbeing. Health expenditure plays
a vital role in universal health coverage, and accessibility to quality and effective health care
services [14].
Infant mortality rate (infants < age 1) and maternal mortality ratio ─ as the two (2) mea-
sures for health outcomes are considered as the core indicators of assessing health care sys-
tems. Infants and women are the most vulnerable in society, hence, infant and maternal
mortality rates are thoughtful indicators when measuring the overall socioeconomic level of a
country [15].
Model estimation
Various models have been employed in the study of panel empirical analysis and likewise
many have been used to estimate the relationship between health outcome and health expendi-
ture. The adoption of panel modelling stems from the utilization of cross-country data across
time-frequency. Our study followed the standard pathway for model estimation using econo-
metric methods. We first examined the descriptive statistics of the data series and examined
the geographical distribution using spatial maps in the form of choropleth. Second, we tested
for panel unit roots to investigate the stationarity of the variables. Third, we tested for panel
cointegration among the variables with modern techniques like Westerlund, Pedroni & Kao
after meeting the preconditions of the panel unit root tests. Fourth, to avoid spurious regres-
sion in the model, the study proceeded to test for the presence of heterogeneity using a modi-
fied Wald test for groupwise heteroskedasticity in a fixed-effect regression model. Because
countries are diversified and are not equal in terms of demographic characteristics, medical
technology, burden of disease, and health infrastructure, among others, we utilized economet-
ric methods that account for such heterogeneities, country-specifics, and unobserved common
factors. Heterogeneous effects of health care expenditure and health outcomes are reported to
affect future convergence towards sustainable health [16]. Hence, the utilization of robust
empirical techniques is essential to the consistency and robustness of the empirical modeling.
The fixed-effect regression model can be expressed as a linear specification presentation in Eq
(1):
ln ðIMRi;tÞjln ðMMRi;tÞ ¼ aþ di þ b� lnCHEi;t þ εi;t ð1Þ
Where ln(IMR) and ln(MMR) represent the logarithmic transformation of infant and
maternal mortality, δi denotes the country-specific fixed effects, α, δi, and β are the parameter
to be estimated, lnCHE is health expenditure and εi,t is the i.i.d error term across countries i in
time t. The output of the estimated parameters is diagnosed using the modified Wald test to
ascertain homoskedastic deviation using the outputted Chi-square statistic.
From the fixed-effects model estimation, the study proceeded to apply the Panel Quantile
Regression (QuanR) estimator with bootstrapping technique for empirical analysis, first for
the whole study period (2000–2015), and secondly, considering the financial crisis (FC) period
by estimating pre (2000–2006), during (2007–2008) and post (2009–2015) FC. To test the qual-
ity of the regression estimate, the empirical analysis produces a goodness-of-fit measure
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(pseudo-R-squared). The following are some of the advantages of QuanR as compared with
standard linear regression (SLR) models [17]:
• QuanR estimates the relationship between the dependent and independent(s) variable(s)
considering the ‘conditional distribution’ while SLR considers the ‘conditional mean
analysis’.
• QuanR has a unique median regression (also known as the least absolute deviations, LAD
estimator) that is additionally robust to outliers and errors that are non-normal when com-
pared to SLR (least square estimates). This makes QuanR more efficient.
• In QuanR analysis, the variable(s) state remains unchanged when logarithmic transforma-
tions are used, easing results interpretation.
The panel QuanR (Q) for this study follows a modified version of the estimator introduced
by Koenker and D’Orey [18]. Eq (2) shows the linear quantile specification, where β(τ) signi-
fies the vector of coefficients associated with the τ–th quantile
t ¼ 0:05; 0:1; . . . . . . ; 0:9; 0:95
For brevity, the modelled equations for the analysis are as follows:
QlnIMRi;t½tjlnCHEi;t;bðtÞ� ¼ a0;t þ b1;tlnCHEi;t i ¼ 1 . . . 177 t ¼ T ð2AÞ
QlnMMRi;t½tjlnCHEi;t;bðtÞ� ¼ a0;t þ b1;tlnCHEi;t ð2BÞ
Results and discussion
Results
Figs 1–3 show the average raw data distribution of IMR, MMR, and CHE across the globe for
the period of study. From the IMR choropleth map (Fig 1) it can be observed that the deep
blue coloured areas are countries with very low infant mortality rates. The countries with
lower IMR can be spotted in Southern America, North America, Europe, Antarctica, Asia
(except Pakistan and Afghanistan), and Australia. Sub-Saharan Africa records the highest IMR
with Democratic Republic of Congo (90.6 deaths per 1000 live births), Central African Repub-
lic (104 deaths per 1000 live births), and Sierra Leone (117 deaths per 1000 live births) as the
top three records for the study period.
The MMR choropleth map (Fig 2) shows that Sierra Leone (1874), Chad (1103), South
Sudan (1007), Central African Republic (1006), and Liberia (952) shows the top five (5) deaths
per 100,000 live births. These countries are all in the Sub-Saharan African region with Sierra
Leone recording the highest average number of maternal deaths for the study period. The low-
est number of maternal deaths are in the other continents except for Afghanistan (718 deaths
per 100,000 live births).
The United States recorded the highest spending (Fig 3) on health (15.2%) for the study
period followed by Micronesia (10.9%), Switzerland (10.74%), Kiribati (10.72%), and Germany
(10.5%). In the sub-Saharan African region Sierra Leone (12.2%), Namibia (10.1%), and
Uganda (9.1%) were recorded as the top three countries with the averaged maximum spending
on health for the study period.
Prior to modelling the nexus between mortality and health expenditure, we conducted a
series of tests including panel unit root and cointegration tests. The variability of mortality and
expenditure (a share of economic growth) makes the data series prone to fluctuations based on
either a common factor or unobserved factors. S3 Appendix in S1 File reveals that some series
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Fig 1. Infant mortality rate distribution across the globe.
https://doi.org/10.1371/journal.pone.0247413.g001
Fig 2. Maternal mortality rate distribution across the globe.
https://doi.org/10.1371/journal.pone.0247413.g002
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in the panel is stationary at first difference, thus, rejecting the null hypothesis that the panel
contains a unit root. The concept of cointegration is only applicable if the variables are inte-
grated of order one, I(1)—as revealed in this study. After testing for panel unit roots, the study
proceeded to examine the panel cointegration of the models using Westerlund, Pedroni, and
Kao tests. The results of the panel cointegration in Table 1 shows a rejection of the null hypoth-
esis of no cointegration at 1% and 5% significant level. This confirms the existence of a level
relationship between health spending (CHE) and health outcomes [mortality (IMR and
MMR)].
Table 1. Panel cointegration using Westerlund, Pedroni & Kao tests.
IMR~f(CHE) MMR~f(CHE)
Westerlund Statistic p-value Westerlund Statistic p-value
Variance ratio 14.0557 <0.0001 Variance ratio 10.6451 <0.0001
Pedroni Pedroni
Modified Phillips-Perron t 9.6750 <0.0001 Modified Phillips-Perron t 6.6939 <0.0001
Phillips-Perron t -3.0517 0.0011 Phillips-Perron t -6.2586 <0.0001
Augmented Dickey-Fuller t 2.1918 0.0142 Augmented Dickey-Fuller t -2.5276 0.0057
Kao Kao
Modified Dickey-Fuller t 11.5504 <0.0001 Modified Dickey-Fuller t 3.7931 0.0001
Dickey-Fuller t 9.3779 <0.0001 Dickey-Fuller t -5.0551 <0.0001
Augmented Dickey-Fuller t 15.6777 <0.0001 Augmented Dickey-Fuller t 1.9953 0.0230
Unadjusted modified Dickey 7.6277 <0.0001 Unadjusted modified Dickey 6.7373 <0.0001
Unadjusted Dickey-Fuller t 1.6754 0.0469 Unadjusted Dickey-Fuller t -2.4979 0.0062
https://doi.org/10.1371/journal.pone.0247413.t001
Fig 3. Health care expenditure across the globe.
https://doi.org/10.1371/journal.pone.0247413.g003
PLOS ONE Mortality and health care expenditure nexus
PLOS ONE | https://doi.org/10.1371/journal.pone.0247413 February 24, 2021 7 / 15
After confirming cointegration among the variables, the study proceeded to test for hetero-
geneity using a modified Wald test for groupwise heteroskedasticity in a fixed-effect regression
model. Heterogeneity in standard panel data models leads to nuisance and spuriousity in esti-
mated parameters if not controlled [19]. Results of the fixed-effect regression in S4 Appendix
in S1 File show that an increase in health expenditure declines both maternal and infant mor-
tality. However, the distributed Chi-squared (χ2) of the modified Wald test statistic shows that
the null hypothesis of homoskedasticity is rejected at 1% significance level—confirming the
presence of heterogeneity in the panel-based estimated model. Thus, a re-estimation of the
panel regression model using econometric techniques that account for heterogeneity was
essential. Similar studies [9, 20] have thus far applied standard econometric techniques based
on mean regression—with statistical inferences that can miss useful policy information due to
cross-sectional dependence and heterogeneity. In contrast, this study applied a panel quantile
regression technique that accounts for unobserved heterogeneity and the conditional distribu-
tion of mortality across quantiles in 177 countries.
The estimation technique employed in this study is based on panel quantile regression with
country-specific fixed effects. Contrary to traditional estimation methods, the panel quantile
regression captures country-specific unobserved heterogeneity uncontrolled for by other
covariates in the estimated model [21]. Hence, the effect of health expenditure on mortality
rate was properly estimated—since idiosyncratic error due to the departure from country-spe-
cific idiosyncratic levels and heterogeneity bias were controlled. Tables 2 and 3 show the
results of the estimated parameters that examine the heterogeneous distributional relationship
between mortality rates and health expenditure. Table 2 shows that the estimated coefficients
from 5th to 95th percentiles are negative and statistically significant at 1% level; however, the
magnitude of the coefficient increases after 40th percentile. The empirical results show that a
1% increase in health expenditure decreases infant mortality by ~0.19 to ~1.45%. Thus, coun-
tries with low infant mortality rate are more responsive to health expenditure compared to
countries with high infant mortality rate. Table 3 reveals negative and statistically significant
coefficients (p<0.01) from 0.05 quantile to 0.95 quantile—in the nexus between maternal mor-
tality rate and heterogeneous health expenditure. In the same manner, a 1% increase in health
expenditure decreases maternal mortality rate by ~0.09 to ~1.91%. In contrast to countries
Table 2. Infant mortality-health expenditure nexus.
lnIMR lnCHE, coef. C R2 S.E QD SP P-value Q.LR
0.05 q -0.8958� [0.0463] 2.9193� [0.0834] 0.0938 1.8461 1.1632 5.1428 <0.0001 215.3996
0.1 q -0.8535� [0.0428] 3.0579� [0.0762] 0.1153 1.6724 1.3350 3.9088 <0.0001 339.1508
0.2 q -1.2456� [0.0406] 4.1564� [0.0778] 0.1441 1.3639 1.8245 3.0642 <0.0001 530.1653
0.3 q -1.4519� [0.0335] 4.8036� [0.0557] 0.1393 1.2019 2.2721 2.6163 <0.0001 580.5745
0.4 q -1.3386� [0.0505] 4.8898� [0.0789] 0.1098 1.0737 2.6946 2.6929 <0.0001 428.1503
0.5 q -1.0839� [0.0418] 4.7632� [0.0648] 0.0887 1.0039 2.9806 2.7313 <0.0001 334.1748
0.6 q -0.8879� [0.0409] 4.7385� [0.0644] 0.0679 1.0396 3.3393 3.0897 <0.0001 223.9271
0.7 q -0.7178� [0.0866] 4.8002� [0.1335] 0.0380 1.1885 3.7257 3.8243 <0.0001 99.7327
0.8 q -0.3812� [0.0521] 4.6298� [0.0797] 0.0197 1.4643 4.0271 2.9460 <0.0001 65.7563
0.9 q -0.2526� [0.0435] 4.6930� [0.0727] 0.0112 1.6874 4.2918 3.0925 <0.0001 35.3947
0.95 q -0.1885� [0.0391] 4.7672� [0.0691] 0.0089 1.8408 4.4578 4.1812 <0.0001 21.1321
Notes: lnCHE, shows the marginal effect, q means Quantile, R2 represents Pseudo R-squared, S.E is the standard error of the regression, QD is the Quantile dependent
var, SP denotes Sparsity, Q.LR means Quasi-LR statistic and P-value is the probability of the Quasi-LR statistic.
� represents 1% significance level (p < 0.01), and the Standard error in parentheses [..].
https://doi.org/10.1371/journal.pone.0247413.t002
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with high maternal mortality rate, the mitigating effect of health expenditure on maternal mor-
tality rate is highly visible in countries with low maternal mortality.
Model validation
Model validation is essential to investigate residual independence, thus, critical for robust
results with unbiased statistical inferences. The estimated panel quantile regression was vali-
dated using diagnostic tests, quantile process coefficient test, slope equality test, and a re-esti-
mation of the models by controlling for global financial crisis shocks. Our panel quantile
regression was estimated using the Markov-Chain Marginal bootstrap method with 10,000
replications for coefficient covariance estimation, and Epanechnikov kernel residual with
Hall-Sheather bandwidth method for sparsity estimation.
Tables 2 and 3 reveal that the sparsity-based Quasi-LR statistic in almost all the quantiles
has a statistically significant probability at 1% level. In Table 4, we examined the quantile slope
equality using Wald test as a robust technique for testing heteroskedasticity. The results of the
conventional test levels for 5th-95th percentiles are significant at 1% level, hence, the condi-
tional quantiles are non-identical and the estimated coefficients in both models differ across
quantiles.
The re-estimation of the models by accounting for the financial crisis shocks—with results
presented in Tables 5–7. For brevity, 5th, 50th, and 95th percentiles—denoting low, medium,
and high mortality (infant and maternal) rates were estimated. In the pre-global financial crisis
(2000–2006) presented in Table 5, the mitigating effect of heterogeneous health expenditure is
high in countries with medium-infant mortality rate, medium in countries with low-infant
mortality rate, and low in countries with high-infant mortality rate. The same trend occurs
with maternal mortality-health expenditure nexus, except that, the impact of health expendi-
ture in countries with high-infant mortality rate turns statistically insignificant—due to identi-
cal conditional quantiles and equal estimated coefficients across quantiles (see p-value of
Quasi-LR statistic at 95th percentile in Table 5).
During the global financial crisis (2007–2008) presented in Table 6, the impact of health
expenditure in reducing both infant and maternal mortality rate is high in medium-infant
mortality rate countries and medium in low-infant mortality rate countries. However, due to
Table 3. Maternal mortality-health expenditure nexus.
lnMMR lnCHE, Coef. C R2 S.E QD SP P-value Q.LR
0.05 q -0.8687� [0.1046] 3.3624� [0.2008] 0.0485 2.8278 1.6094 8.1874 <0.0001 98.9611
0.1 q -1.0772� [0.0764] 4.0381� [0.1403] 0.0682 2.5669 1.9459 5.6789 <0.0001 195.6367
0.2 q -1.5281� [0.0809] 5.4442� [0.1581] 0.0937 2.1081 2.4849 4.6194 <0.0001 327.7249
0.3 q -1.8500� [0.0638] 6.3825� [0.1183] 0.1095 1.8910 3.2189 3.7656 <0.0001 469.1974
0.4 q -1.9095� [0.0639] 6.8720� [0.1060] 0.0896 1.7194 3.6889 3.9471 <0.0001 361.5214
0.5 q -1.5591� [0.0721] 6.7394� [0.1067] 0.0716 1.5861 4.1271 4.5212 <0.0001 252.7391
0.6 q -1.2956� [0.0808] 6.7822� [0.1317] 0.0622 1.6068 4.7005 4.9889 <0.0001 202.0883
0.7 q -1.0002� [0.1399] 6.9252� [0.2367] 0.0383 1.8577 5.3845 6.7938 <0.0001 91.8318
0.8 q -0.5353� [0.0936] 6.8438� [0.1345] 0.0108 2.3369 6.0064 5.8254 <0.0001 29.8214
0.9 q -0.2841� [0.0703] 6.9598� [0.1178] 0.0041 2.7759 6.4831 4.8821 <0.0001 13.1772
0.95 q -0.0896� [0.0505] 6.8195� [0.0827] 0.0013 2.9484 6.6758 5.8014 <0.0001 3.4731
Notes: lnCHE, shows the marginal effect, q means Quantile, R2 represents Pseudo R-squared, S.E is the standard error of the regression, QD is the Quantile dependent
var, SP denotes Sparsity, Q.LR means Quasi-LR statistic and P-value is the probability of the Quasi-LR statistic.
� represent 1% significance level (p < 0.01), and the Standard error in parentheses [..].
https://doi.org/10.1371/journal.pone.0247413.t003
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identical conditional quantiles and homogeneous coefficients across quantiles in both models,
the effect of health expenditure on mortality in high-mortality rate countries becomes insignif-
icant (see p-value of Quasi-LR statistic at 95th percentile in Table 6).
In the post-global financial crisis (2009–2015) presented in Table 7, health expenditure
negates both infant and maternal mortality in medium mortality rate countries by 1.15%
(infant) and 1.57% (maternal), low mortality rate countries by 0.84% (infant) and 0.86%
(maternal), and countries with high-infant mortality rate by 0.15%. In contrast, the impact of
health expenditure on maternal mortality in countries with high-maternal mortality rate turns
statistically insignificant due to the equal coefficients across quantiles and identical conditional
quantiles (see p-value of Quasi-LR statistic at 95th percentile in Table 7).
To test the robustness of the estimated parameters, we employed quantile process coeffi-
cient test based on a graphical representation depicted in S5 Appendix in S1 File. A visual
inspection of the corresponding figures reveal that the estimated coefficients are within the
95% confidence band, hence, confirms the robustness and stability of the estimated models.
Table 4. Quantile slope equality test summary.
Wald Test Chi-Sq. Statistica Prob. a Chi-Sq. Statisticb Prob. b
5th percentile 833.6807 <0.0001 503.9763 <0.0001
10th percentile 833.3980 <0.0001 495.5384 <0.0001
20th percentile 833.3980 <0.0001 495.7348 <0.0001
30th percentile 828.4113 <0.0001 495.5384 <0.0001
40th percentile 833.3980 <0.0001 495.7348 <0.0001
50th percentile 828.4113 <0.0001 495.7370 <0.0001
60th percentile 833.3980 <0.0001 495.7348 <0.0001
70th percentile 833.3980 <0.0001 495.9524 <0.0001
80th percentile 829.4048 <0.0001 496.1406 <0.0001
90th percentile 833.3980 <0.0001 495.9313 <0.0001
95th percentile 941.9810 <0.0001 713.4720 <0.0001
Notes
a denotes model specification lnIMR~f(lnCHE) while
b denotes lnMMR~f(lnCHE)
https://doi.org/10.1371/journal.pone.0247413.t004
Table 5. Mortality-health expenditure nexus from 2000–2006 (pre-global financial crisis).
lnCHE, Coef. C R2 S.E QD SP P-value Q.LR
lnIMR
0.05 q -0.8296� [0.0532] 2.9246� [0.0907] 0.0916 1.8581 1.3350 5.1107 <0.0001 90.4516
Median q -1.0576� [0.0637] 4.8369� [0.0886] 0.0670 1.0075 3.1485 2.9565 <0.0001 101.0224
0.95 q -0.1794� [0.0410] 4.8447� [0.0658] 0.0116 1.7863 4.5716 3.6503 0.0003 13.1936
lnMMR
0.05 q -1.1247� [0.1705] 3.9330� [0.3155] 0.0509 2.7927 1.7918 8.0718 <0.0001 45.8481
Median q -1.6587� [0.1150] 6.9313� [0.1886] 0.0750 1.5954 4.2195 4.2434 <0.0001 122.9733
0.95 q -0.1105 [0.0955] 6.9224� [0.1523] 0.0007 2.8993 6.7662 5.6710 0.3409 0.9071
Notes: lnCHE, shows the marginal effect, q means Quantile, R2 represents Pseudo R-squared, S.E is the standard error of the regression, QD is the Quantile dependent
var, SP denotes Sparsity, Q.LR means Quasi-LR statistic and P-value is the probability of the Quasi-LR statistic.
� represents 1% significance level (p < 0.01), and the Standard error in parentheses [..].
https://doi.org/10.1371/journal.pone.0247413.t005
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Discussion
As this study sought to add its contribution to the growing debate by studying CHE impact on
IMR and MMR for the MDGs year-span (2000–2015) using QuanR as well as considering the
Financial Crisis (FC) period of 2007–2008 [22].
Empirical analysis results show that the relationship between health expenditure and IMR and
MMR are statistically significant with varying degrees of positive impact across the 11 quantiles for
the first part of the analysis without considering FC periods. An increase in health expenditure by
1% shows a relatively greater reduction on infant deaths from the 20th percentile to the median
with a significant impact at the 30th percentile by ~1.45%, while that of maternal deaths is observed
between the 10th– 70th percentile and majorly at the 40th percentile by ~1.91%. Increasing health
expenditure shows minimal impact at the upper end of the conditional distribution (80th– 95th
percentile). Results by Akinlo and Sulola [23] disagree with our outcome on health expenditure
reducing infant mortality but the findings by Rana, Alam [9] and Nicholas, Edward [24] are con-
sistent with ours. The empirical results of the nexus between maternal mortality and health expen-
diture by Nicholas, Edward [24] and Rana, Alam [9] are inconsistent with our outcome.
The results infer that although health expenditure increase reduces IMR and MMR for all
economies under-study, countries at the verge of beginning their mid-income status or
Table 7. Mortality-health expenditure nexus from 2009–2015 (post-global financial crisis).
lnCHE, Coef. C R2 S.E QD SP P-value Q.LR
lnIMR
0.05 q -0.8404� [0.0620] 2.7094� [0.1205] 0.0917 1.8282 0.9555 5.5402 <0.0001 83.8396
Median q -1.1533� [0.0715] 4.7872� [0.1056] 0.1089 0.9821 2.7973 2.7400 <0.0001 177.5534
0.95 q -0.1523� [0.0549] 4.4985� [0.0912] 0.0088 1.7948 4.2781 3.8592 0.0018 9.7249
lnMMR
0.05 q -0.8592� [0.1315] 3.2725� [0.2583] 0.0496 2.8060 1.6094 7.8789 <0.0001 45.7502
Median q -1.5718� [0.1257] 6.7475� [0.1651] 0.0773 1.5651 4.0254 5.0378 <0.0001 107.0256
0.95 q -0.1015 [0.1030] 6.7037� [0.1716] 0.0005 2.9326 6.5681 6.5027 0.4532 0.5626
Notes: lnCHE, shows the marginal effect, q means Quantile, R2 represents Pseudo R-squared, S.E is the standard error of the regression, QD is the Quantile dependent
var, SP denotes Sparsity, Q.LR means Quasi-LR statistic and P-value is the probability of the Quasi-LR statistic.
� represents 1% significance level (p < 0.01), and the Standard error in parentheses [..].
https://doi.org/10.1371/journal.pone.0247413.t007
Table 6. Mortality-health expenditure nexus from 2007–2008 (during the global financial crisis).
lnCHE, Coef. C R2 S.E QD SP P-value Q.LR
lnIMR
0.05 q -0.8232� [0.1688] 2.7234� [0.3103] 0.0809 1.8960 1.1632 5.8691 <0.0001 20.0304
Median q -1.0183� [0.1452] 4.6225� [0.2313] 0.0674 1.0224 2.9339 3.0025 <0.0001 28.6970
0.95 q -0.0878 [0.0669] 4.5723 [0.1165] 0.0070 1.8356 4.4140 4.4237 0.1704 1.8792
lnMMR
0.05 q -0.6308� [0.2696] 2.8086� [0.5111] 0.0371 2.9516 1.6094 8.3313 0.0024 9.2444
Median q -1.2204� [0.2522] 6.1326� [0.3992] 0.0385 1.6212 4.0775 5.0038 0.0001 15.4118
0.95 q 0.0809 [0.1545] 6.5077� [0.2677] 0.0005 2.9557 6.6134 6.9039 0.7051 0.1432
Notes: lnCHE, shows the marginal effect, q means Quantile, R2 represents Pseudo R-squared, S.E is the standard error of the regression, QD is the Quantile dependent
var, SP denotes Sparsity, Q.LR means Quasi-LR statistic and P-value is the probability of the Quasi-LR statistic.
� represents 1% significance level (p < 0.01), and the Standard error in parentheses [..].
https://doi.org/10.1371/journal.pone.0247413.t006
PLOS ONE Mortality and health care expenditure nexus
PLOS ONE | https://doi.org/10.1371/journal.pone.0247413 February 24, 2021 11 / 15
developing nations will benefit more in reducing death rate than countries categorised as least
developed and developed economies. This can perhaps be explained by environmental and
health awareness with increasing level of income that moderates the greater effect of healthcare
expenditure on infant and maternal mortality rates across countries en route to middle-income.
The findings can be attributed to the fact that in low-income economies, an increase in health
expenditure mitigates mortality rates to an extent. Other factors such as delay in seeking proper
medical attention, self-medication, among others (education, infrastructural problems, resource
allocation, poor sanitation, health governance, etc.) cannot be overlooked as contributing factors.
A study by Bhalotra [6] on health spending and infant mortality in India showed that health
spending do not save infants from death, however, by considering certain specifications such as
‘mother’s age at birth’, ‘education’, etc. they found otherwise corroborating the point made ear-
lier. Thus, the share of GDP for the health sector in developing countries should be enhanced
due to its role in mitigating IMR and MMR. In high-income countries, other unaccounted fac-
tors in this study might exacerbate mortality rates, hence, further research will be worthwhile.
The 2007–2008 FC period showed no causal relationship between CHE and IMR and
MMR for developed nations (95th quantile). The results of least-developed (5th quantile) and
developing (50th quantile) countries were similar to pre-, during, and post- global FC in reduc-
ing IMR and MMR. The FC period did have an effect on mortality (IMR and MMR), this effect
was observed prominently for the median quantile of maternal mortality ratio since the mar-
ginal coefficient of lnCHE during the FC period (2007–2008) was less (~1.22%) compared to
the pre-FC (~1.66%) and post-FC (~1.57) period.
In summary Fig 4 illustrates that in general, as health expenditure is increased, infant mor-
tality and maternal mortality decreases. A visual inspection of Fig 4 and graphs in S5 Appendix
in S1 File. shows that health expenditure can only mitigate mortality rates to an extent.
Fig 4. Infant mortality rate and maternal mortality ratio distribution across the globe.
https://doi.org/10.1371/journal.pone.0247413.g004
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To have a lasting solution further studies should focus on the health care system as a whole
and ways to minimize corrupt practices in least-developed and developing economies [25].
There is evidence of female education reducing infant mortality [4], hence, governments and
stakeholders should put measures in-place to formally educate several women.
Conclusion
The nexus between health expenditure, infant mortality rate, and maternal mortality ratio has
been studied extensively over the years. In the extant literature, most of the analysis between
health expenditure and health outcome employed models that consider the conditional mean
analysis. In contrast, this paper employed the conditional distribution analysis (Quantile
Regression) to study the effect of health expenditure on health outcomes for the period 2000–
2015 for 177 countries. Secondly, the study considered the global financial crisis of 2007–2008.
The results showed a significant positive relationship between health expenditure and infant
mortality rate, and maternal mortality ratio for the study period across 11 quantiles ─ with the
most impact observed in developing economies.
Considering the effect of the global financial crisis (2007–2008), health expenditure had a
mitigating effect on infant and maternal mortality for least developed and developing econo-
mies contrary to developed countries. Multidimensional poverty is often high in developing
countries, especially low-income economies, hence, limits access to affordable healthcare sys-
tem. Thus, healthcare policies in developing countries that favour the poor contribute signifi-
cantly in improve health and wellbeing. The removal of fiscal barriers to proper healthcare in
poor countries is reported to reduce mortality while improving health outcomes. Factually,
these inferences draw our attention that, increasing health care expenditure mitigates mortality
to an extent. Therefore, as the study period showed that health expenditure does reduce mor-
tality in the MDG’s era (2000–2015), there is no doubt that increasing health spending will
play a vital role in reducing mortality and aid in achieving SDG 3.
This study confirmed the nexus between health expenditure, infant-, and maternal mortal-
ity ─ showing that an increase in health expenditure will decline maternal deaths contrary to
other reported literature that found no significant causal relationship.
We further observe from the mapping that Senegal’s health expenditure spending is rela-
tively high compared to other African countries in the sub-region, however, its mortality rates
are also high. This could be attributed to misappropriation of funds or other underlying factors
in the health care system including limited health facilities, lack of infrastructure, lack of quali-
fied personnel, and lack of medication. This challenges cut across in several developing econo-
mies, hence, an indepth research into the specific cause(s) is warranted. Therefore, the
institution of sustainable healthcare-related measures will further reduce infant and maternal
deaths. Further research should focus on other measures that have a significant influence on
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